The effects of clovoxamine on sleep of normal volunteers: A double-blind placebo-controlled study
β Scribed by William H. Wilson; Thomas Ban; Bernard Coleman; Beth Vause; John Papadatos
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 351 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
β¦ Synopsis
In a double-blind placebo-controlled study the effects of clovoxamine on sleep were evaluated. Each of 12 healthy male volunteers was given clovoxamine (50 and 150 mg) and placebo according to a repeated-measures randomized Latin square design. All night sleep EEGs and subjective evaluations of sleep were recorded on each night. Clovoxamine was found to have effects on sleep EEG and subjective evaluation that were consistent with findings reported for other antidepressants such as imipramine.
π SIMILAR VOLUMES
In a multinational, double-blind, placebo-controlled trial (NCT00474058), 287 subjects with Parkinson's disease (PD) and unsatisfactory early-morning motor symptom control were randomized 2:1 to receive rotigotine (2β16 mg/24 hr [n = 190]) or placebo (n = 97). Treatment was titrated to optimal dose
The purpose of this study was to compare the cognitive eect of two medications frequently prescribed to patients suering from insomnia. Using a double-blind design, we evaluated three parallel groups of 20 insomniac patients treated over a period of 3 weeks with zopiclone, temazepam and placebo, res
## Abstract ## Objective To confirm preclinical data suggesting that doxycycline can slow the progression of osteoarthritis (OA). The primary outcome measure was joint space narrowing (JSN) in the medial tibiofemoral compartment. ## Methods In this placeboβcontrolled trial, obese women (n = 431)
This double-blind, placebo-controlled, crossover study examined the effects of two single doses of eptastigmine, a novel cholinesterase inhibitor, on scopolamine-induced cognitive deficits in 24 healthy male volunteers. Each subject received the following treatment sequences, separated by at least 1